This study is aimed to compare the duration of standard anti fungal therapy in high risk ICU patients with a strategy driven by BetaDGlucan test result
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
120
Patients in the study group will stop antifungals in presence of a negative result of Beta Glucan Test
Gennaro De Pascale
Rome, Italy
Reduction of anti fungal duration in the Beta Glucan group compared with standard empirical approach
Time frame: First 30 days from enrollment
Clinical Cure of Invasive Canididiasis
Time frame: 90 days
Microbiological eradication of Invasive Candidiasis
Time frame: 90 days
30-day mortality
Time frame: 30 days
ICU mortality
Any cause ICU mortality within three months from enrollment
Time frame: 90 days
Hospital mortality
Any cause hospital mortality within three months from enrollment
Time frame: 90 days
Duration of ICU length of stay
Time frame: 90 days
Duration of mechanical ventilation
Time frame: 90 days
Number of invasive Candida Infections and Beta-Glucan accuracy
Time frame: 90 days
Cost evaluation (empirical anti fungal therapy vs. Beta Glucan test)
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.